|

Butyrophilins Role in Colon Cancer

RECRUITINGN/ASponsored by Institut Paoli-Calmettes
Actively Recruiting
PhaseN/A
SponsorInstitut Paoli-Calmettes
Started2020-06-30
Est. completion2027-06-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04185272

Summary

quantification of BTNL molecules in colon cancer in order to determinate if their could be used as a prognostic marquer

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patient is older than 18 years old,
* Signed participation consent,
* Non-metastatic colon cancer immediately resectable or metastatic and liver synchronous for which it was decided a combined colic and liver surgery (metastatic patient at the outset) in multidisciplinary consultation meeting.
* Performance Status (PS) 0 or 1
* affiliated to the social security or beneficiary

Exclusion Criteria:

* Rectal cancer, colon cancer recurrence
* Emergency of colon cancer Surgery
* History of inflammatory disease of the digestive tract (Crohn's disease or ulcerative colitis)
* Patient who received neoadjuvant therapy other than chemotherapy
* Patient treated with immune-suppressors or long-course corticosteroids \<12 months
* Pregnant women or likely to be pregnant (without effective contraception) or breastfeeding,
* Person in urgent situation, person under legal protection measure, or unable to express his / her consent,
* Impossibility of submitting to the medical examination of the test for geographical, social or psychological reasons

Conditions2

CancerColonic Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.